News for Industry

Researchers Replicate Alzheimer’s Brain Cells In a Petri Dish (Boston Globe)
(Boston, MA) A petri dish with human brain cells that develop structures specific for Alzheimer’s disease, opening the door for potential drug therapy.

New Physical Makers for MSCs in Bone Marrow Identified (Imperial Valley News)
(Cambridge, MA) Researchers identify 3 physical characteristics of mesenchymal stem cells that can distinguish them from other immature cells found in bone marrow.

Stem Cell Agency Invests $16 million To Fight Diabetes (Imperial Valley News)
(San Francisco, CA) The California Institute for Regenerative Medicine (CIRM) awarded $60 million to researchers hoping to accelerate the development of a treatment for type I diabetes.

Insurers In Japan Will Soon Offer Coverage to Cell-Cultivating Companies (Live Insurance News)
(Tokyo, Japan) The non-life insurance companies in Japan will begin to sell policies to cover the cultivation of stem cells for regenerative medicine procedures.

Accurexa Announces License For UCSF Brain Stem Cell Device (Bay Street)
(San Francisco, CA) The University of California, San Francisco announced that it has entered into an exclusive license agreement with Accurexa, Inc for global licensing of a medical stereotactic device.

BioTime’s Cell Cure Neurosciences Ltd. Demonstrates Safety and Efficacy of OpRegen® in Animal Studies (Market Watch)
(Alameda, CA) BioTime Inc. completed a series of extensive preclinical safety and efficacy studies for its product OpRegen intended for treatment of dry age-related macular degeneration.

New Stem Cell Bio Drug for Bone Regeneration To Be Released in January (Miami Today News)
(Miami, FL) An adult bone marrow isolated multi-lineage inducible cell called the Miami cell.

Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market (CNN)
(Haifa, Israel) Pluristem Therapeutics Inc. a leading developer of placenta-based cell therapy products is evaluating strategic opportunities to co-develop and commercialize cell therapy products in Japan.

Scientists Create Therapy-Grade Stem Cells Using New Cocktail to Reprogram Adult Cells (Phys)
(Jerusalem, Israel) Researchers at the Hebrew University of Jerusalem have developed a new formulation that is highly effective in transforming adult stem cells into quality pluripotent stem cells.